Portfolio Companies 2026 for Orbimed: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Orbimed accounts for 8 tracked companies with verified cap-table data, 8 of which disclose round sizes totalling $2.3B. The median disclosed raise is $247M, and the largest is Miaoshou Doctor at $933M, ahead of Insilico Medicine ($416M) and Zhaoke Ophthalmology Pharmaceutical ($395M).
The names that recur most often on these portfolio cap tables are Orbimed (8 companies), Tencent (1 company), Sequoia Capital China (1 company), Warburg Pincus (1 company), Sequoia Capital (1 company), Mirae Asset Financial Group (1 company). By latest disclosed round, the market skews Series D (2), Series B (2), Series F (1), Series E (1).
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide